Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 718 (ZNF718) is a predicted human transcription factor, part of the large zinc finger protein family, characterized by zinc finger DNA-binding domains and thought to regulate gene expression by binding specific cis-regulatory elements in the genome. ZNF718 is believed to enable DNA-binding transcription factor activity specific to RNA polymerase II and may be involved in the regulation of DNA-templated transcription, primarily located in the cell nucleus. ZNF718, like many C2H2-type zinc finger proteins, may play roles in transcriptional activation or repression, but specific target genes, interacting partners, or physiological functions have not been established experimentally. There is no current evidence that ZNF718 functions as a therapeutic target or is implicated directly in disease pathways.
None known. No drugs or small molecules are known to target ZNF718, so no mechanisms of action are defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 718 (ZNF718).